Quarterly ResultJun 2, 2026, 06:06 AM
Optimi Health Reports Wider Net Loss, Lower Revenue; Completes Nasdaq IPO
AI Summary
Optimi Health Corp. reported a significant increase in net loss to $3,145,846 for the six-month period ended March 31, 2026, compared to $1,455,346 in the prior year. Revenue also saw a sharp decline to $99,500 from $293,941. The company executed a 1-for-30 reverse stock split and subsequently raised approximately CAD$18.4 million through a Nasdaq public offering. Despite these capital raises, the company faces a working capital deficiency and expresses substantial doubt about its ability to continue as a going concern.
Key Highlights
- Optimi Health reported a net loss of $3,145,846 for the six-month period ended March 31, 2026, compared to a net loss of $1,455,346 for the same period in 2025.
- Revenue for the six-month period ended March 31, 2026, was $99,500, a decrease from $293,941 in the prior year period.
- The company completed a 1-for-30 reverse stock split on May 19, 2026.
- Optimi Health raised approximately CAD$18.4 million in net proceeds from a public offering on the Nasdaq Capital Market.
- Total assets decreased to $13,509,676 as of March 31, 2026, from $15,212,645 as of September 30, 2025.
- Total liabilities increased to $9,971,230 as of March 31, 2026, from $8,641,984 as of September 30, 2025.
Price Impact
More from OPTH